CLINICAL_TRIALS
trial_result
· 2025-07-28
Clinical Trial Update: Dose Reduction and Discontinuation With Anti-Fibrotic Medications
Summary
A completed Boehringer Ingelheim trial update evaluating dose reduction and discontinuation patterns with anti-fibrotic therapy in idiopathic pulmonary fibrosis…
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: Boehringer Ingelheim | Conditions: Idiopathic Pulmonary Fibrosis | Status: COMPLETED | Results posted: 2025-07-28